ATEROZ

ATEROZ is a branded generic formulation of atorvastatin calcium, a small molecule HMG-CoA reductase inhibitor (statin) developed and manufactured by Bilim Pharmaceuticals. It is indicated for the treatment of primary hypercholesterolemia (both heterozygous familial and nonfamilial), mixed dyslipidemia, homozygous familial hypercholesterolemia, and hypertriglyceridemia, as well as for the prevention of cardiovascular events. By inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, ATEROZ reduces total cholesterol, LDL cholesterol, apolipoprotein B, and triglycerides while increasing HDL cholesterol levels. It is available as film-coated tablets in 10 mg, 20 mg, and 40 mg strengths and is marketed in Turkey and other international markets.

Brand names

ATEROZ

Other names

atorvastatinatorvastatin calcium